The development of antibody-drug conjugates (ADCs) has progressed significantly over the past decade due to improvements in payloads, linkers, and conjugation methods. In particular, linker design plays a key role […]
The development of antibody-drug conjugates (ADCs) has progressed significantly over the past decade due to improvements in payloads, linkers, and conjugation methods. In particular, linker design plays a key role […]
The concept of arming antibodies by conjugation to protein toxins dates back to 1970, and was followed a few years later by antibody conjugates with cytotoxic drugs. Antibody therapeutics have come of age […]